Acadia Pharmaceuticals sell The Goldman Sachs Group, Inc.
Start price
07.08.25
/
50%
€20.93
Target price
07.08.26
€14.58
Performance (%)
-0.19%
Price
24.02.26
€20.89
Summary
This prediction is currently active. The SELL prediction by The_Goldman_Sachs_Gr for Acadia Pharmaceuticals is nearly unchanged. This prediction currently runs until 07.08.26. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Acadia Pharmaceuticals | 7.903% | 7.903% |
| iShares Core DAX® | 0.024% | 0.583% |
| iShares Nasdaq 100 | 1.740% | -2.061% |
| iShares Nikkei 225® | 0.428% | 10.487% |
| iShares S&P 500 | 1.329% | 0.140% |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $15.00 to $17.00. They now have a "sell" rating on the stock.
Ratings data for ACAD provided by MarketBeat